MAZE

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to developing small molecule precision medicines aimed at treating renal, cardiovascular, metabolic diseases, and obesity. Utilizing advanced genetic insights, the company is advancing a robust pipeline of innovative therapies designed to tackle substantial unmet medical needs. As it progresses through key clinical stages, Maze Therapeutics is strategically positioning itself at the forefront of the precision medicine sector, poised to make significant contributions to patient care and transform treatment paradigms in its target areas.